Cheepsattayakorn  graduated  Doctor  of  Medicine  from  Chiang  Mai  Medical  School, Chiang  Mai  University, Chiang  Mai, Thailand  in  1986.  He  then  further  had  trained  in  Internal  Medicine,   Pulmonology, and  Radiology  at  Chiang  Mai  University  Medical School.  Recently, on  October  26, 2019, he  was  bestowed  the  Gold  Medal  Award (First-Class  Award)  from  the  Chiang  Mai  University  Medical  School  Alumni  Association  in  Chiang  Mai, Thailand  for  his  academic  and  medical  practice  excellence  for  cerebrating  the  60th  Anniversary  of  the  Chiang  Mai  University  Medical  School, Chiang  Mai, Thailand  that  was  established  on  October  28, 1959.  He    graduated  numerous  Fellowships  from  the  Royal  Colleges  of  Physicians  of  Edinburgh, London  and  Thailand, Royal  College  of  Physicians  and  Surgeons  of  Glasgow, American  College  of  Physicians, and  American  College  of  Chest  Physicians.  Presently, he  serves  both  Editor  and  Editorial  Board  Member  and  also  referee  of  several  international  journals. 

  He  has  very  high  experience  in  the  fields  of  Pulmonary  Diseases  and  Tuberculosis  including  Infectious  Diseases  and  Immunology.  He  has  numerous  scientific  publications, more  than  300  publications  both  in  national  and  international  journals  and  books, including  authored  textbook  of  COVID-19, “ Thailand’s  and  Global  Perspectives  of  COVID-19 ”, both  the  United  Kingdom  version (361  pages, first  edition  published  by  the  Medical  and  Research  Publications  in  2021)  and  the  United  States  of  America  version (367  pages, second  edition  published  by  the  Science  and  Education  Publishing  in  2022).  He  had  been  served  as  Pulmonologist  and  Senior  Expert  Level  11 (Highest  Level-equivalent  to  Professor  of  Medicine  Level  11), Department  of  Disease  Control, Ministry  of  Public  Health, Thailand.  He  serves  as  Faculty  Member  of  the  Faculty  of  Medicine, Western  University, Thailand. 

Currently, he  also  serves  the  International  Regional  Adviser (Advisory  Board)  for  Thailand  of  the  Royal  College  of  Physicians  of  Edinburgh, United  Kingdom  and  the  Reviewer  for  the  journals  of  the  Royal  College  of  Physicians  of  London, United  Kingdom.   He  was  appointed  the  Japan  International  Cooperation  Agency (JICA)’s  Advisor  in  2021-2022.  He  was  directly  invited  &  proposed  to  the  World  Federation  of  United  Nations  Associations (WFUNA)  Membership  by  the  United  Nations  Former  Secretary-General  “ H.E.  Ban  Ki-Moon ”. Recently, he  has  been  approved  for  the  Membership  of  the  WFUNA  since  4  January  2022 (Ref. : UN-467-NYUN)  and  has  been  appointed  the  WFUNA  Membership  signed  by  the UN authorities (the  UN Secretary-General, the  UN President of the General  Assembly, and  the  UN  President  of  the  Security  Council)  since  January  15, 2022.

Brian T. Regan serves as Chief Strategy Officer for Grignard Pure, LLC, an innovative science and technology company developing next-generation solutions for eliminating airborne pathogens in all indoor environments from healthcare, to food processing, to workplaces, schools, and homes. He is responsible for shaping and executing Grignard Pure’s go-to-market strategy, integrating science, IP, regulatory, product development and partner engagement into successful implementation. Prior to joining Grignard Pure in January 2021, he spent twenty-five years working with organizations from start-ups to Fortune 500 companies, helping position them for optimal competitiveness in the markets they serve. Among those companies he counseled include Virgin, EMC, CA Technologies, Intuit, MongoDB, Docusign, and Philips.

Gediminas “Gedi” Mainelis is a Professor in the Department of Environmental Sciences at Rutgers, the State University of New Jersey, USA. He has a Bachelor’s degree in physics from Vilnius University, Lithuania, and a Ph.D. in Environmental Health from the University of Cincinnati, Ohio, USA. His research focuses on various aspects of bioaerosol science, including sampling and analysis methods, exposure assessment, and airborne microbiomes. Over the past years, his research expanded to investigate exposures to manufactured nanoparticles and explore indoor air issues. Several of his current projects focus on COVID-19 issues. His research efforts have resulted in more than 110 peer-reviewed publications, book chapters, and several patents. In addition, multiple papers from his group have been included in the most downloaded article lists of various peer-reviewed journals. Dr. Mainelis has served as Chair of the Bioaerosols and Health-Related Aerosol working groups of the American Association for Aerosol Research (AAAR). He is currently an editor (associate) of the Aerosol and Air Quality Research journal. Prof. Mainelis is a recipient of the Research Excellence Award from Rutgers University and the Lyman A. Ripperton Environmental Educator Award presented by the A&WMA.

Scientist and Clinician, NHS physician at the Royal Papworth Hospital Cambridge, discoverer of first effective therapies for Pulmonary Arterial Hypertension [PAH] (iv. Prostacyclin and Inhaled NO). Established the UK National Network of PAH centres. Professor, Medicine Sheffield University Medical School and Senior Principal Scientist AstraZeneca plc, Corporate Clinical Director Chiesi Farmaceutici (Italy), Architect of the first triple inhaler for asthma/COPD Trimbow®, Senior Partner TranScrip LLP, R&D Director Allergy Therapeutics plc, Vice President, and President Faculty of Pharmaceutical Medicine Royal Colleges of Medicine UK. CEO and founder of Camcon Robotics Ltd.

Verin completed his Ph.D. at the age of 29 years from Moscow State University, Moscow, USSR, and postdoctoral studies at the University of Indiana. During his scientific carrier, he was a faculty member at Johns Hopkins and the University of Chicago. Currently, he is a Professor at the Vascular Biology Center and Pulmonary Division, School of Medicine, Medical College of Georgia, at Augusta University, Augusta, GA.   He has published more than 170 papers in reputed journals primarily in the field of pulmonary vascular endothelial barrier regulation.  He served as an Editorial board member of the American Journal of Physiology (Lung) from 2006-2011 and Editor-in-chief of the academic journal, Vessel Plus, in 2016-2022. He is currently serving as an academic editor of the British Journal of Medicine and Medical Research and Cardiology and Angiology, and an editorial board member in several other journals in the field of pulmonary/cardiovascular research such as Biomolecules, Cardiovascular Pharmacology, Journal of Multidisciplinary Pathology, Tissue Barriers, World Journal of Respirology.

Mitch Simpler joined JB&B, a global consulting engineering firm, in 1977 and currently serves as a partner after having served as Managing Partner from 2012- 2018. He has acted as project manager and partner-in-charge on life/health science institutions, health care facilities, high-rise office buildings, museums, residential and mixed-use buildings, as well as hotels. Simpler’s list of notable projects in the life science sector spans the past 45 years, including premier laboratory facilities and research centers in New York City, such as the Jerome L. Greene Science Center at the Columbia University Manhattanville campus, The East River Science Park in New York, the New York Genome Center, Mount Sinai’s Hess Center for Science and Medicine, Weill Cornell Medical College’s Belfer Research Building, MSK’s David H. Koch Center for Cancer Care and Rockefeller Research Laboratories, Cornell University’s Biotechnology Building, and NYU Langone Health’s Smilow Research Building and Skirball Institute of Biomolecular Medicine. His experience extends around the world to China, with the Innovation Center at Duke Kunshan University in Kunshan and the Rohm & Haas Research Center in Shanghai. Mr. Simpler is a fellow of the American Council of Engineering Companies (ACEC) and recently served as the National Chairman of ACEC. He is also a founding member and Co-Founder of NYC Builds Bio+.